Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-120 in Non-Constipating IBS
NCT00583128Phase 2Completed
- Sponsor
- Ocera Therapeutics
- Start
- Aug 2007
- Primary completion
- May 2010
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 2
01
Overview
A Phase 2 trial of activated charcoal in irritable bowel syndrome (IBS), sponsored by Ocera Therapeutics. Started Aug 2007; status: completed.
02
Drugs
activated charcoal
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00583128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00583128.